Life Sciences

Finding sustainability in biotechnology, pharmaceutical and medical technology

Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.

Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.

We cover key issues in these areas:




Connect with us

Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.

Infographic: Turning the tide on cancer drug costs

EY - Infographic: Turning the tide on cancer drug costs

The Healthcare Forum - War on cancer

EY - The Healthcare Forum - War on cancer

A unified battle plan for the 21st century - October 20th 2015. Summary paper.


Video: The patient/payer debate — balancing clinical need and affordability

EY - The patient/payer debate - balancing clinical need and affordability

The video was filmed at The Economist War on Cancer Summit – October 2015

Speakers:

  • Silvia Ondategui-Parra, Partner – MED Healthcare and Life Sciences Leader – Commercial Market Access Leader, EY
  • Paul Catchpole, Value and Access Director of The Association of the British Pharmaceutical Industry
  • Carole Longson, Director of the Centre for Health Technology Evaluation and Executive Director for the National Institute for Health and Care Excellence (NICE)
  • Peter Clark, Oncologist and Chairman of the Cancer Drugs Fund